Biocept Stock Quote BIOC - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.4349

Bid

0.37

Ask

0.3799

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

0.4349

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Form 8-K - Current report

Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer...

Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus...

Biocept to Participate in the H.C. Wainwright Global Investment Conference

Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that management will participate in the H.C...

Biocept to Hold Business Update Conference Call on August 30, 2023

Biocept, Inc. (Nasdaq: BIOC) management will hold a conference call on August 30, 2023, beginning at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) to provide a business update and to answer...

Form 8-K - Current report

Biocept Reports Second Quarter 2023 Financial Results

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and six months ended June 30, 2023 and provides a...

Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference

Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that its CNSide cerebrospinal fluid assay was...

Biocept Announces the Passing of Board Chair M. Faye Wilson

Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”) announces that M. Faye Wilson, Board Chair, passed away unexpectedly on Monday, July 10. The Board of Directors and staff of Biocept...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

BIOC - Frequently Asked Questions (FAQ)

What is the current Biocept share price?

The current share price of Biocept is $ 0.4349

What is the 1 year trading range for Biocept share price?

Biocept has traded in the range of $ 0.00 to $ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BACKIMAC Holdings Inc	$ 1.58 (90.59%)	20.33M
YIBOPlanet Image International Ltd	$ 5.85 (89.94%)	13.72M
FORLFour Leaf Acquisition Corporation	$ 17.91 (60.20%)	12
GDSTGoldenstone Acquisition Ltd	$ 18.55 (59.09%)	58
IROHIron Horse Acquisition Corporation	$ 16.47 (58.98%)	6
TMCITreace Medical Concepts Inc	$ 4.00 (-58.76%)	197
STSSSharps Technology Inc	$ 0.617 (-57.74%)	266.88k
HCVIHennessy Capital Investment Corporation VI	$ 6.01 (-43.89%)	5
CCECCapital Clean Energy Carriers Corporation	$ 13.01 (-29.68%)	13
FSTRL B Foster Company	$ 19.12 (-29.21%)	14
HEPAHepion Pharmaceuticals Inc	$ 0.2172 (31.64%)	22.74M
BACKIMAC Holdings Inc	$ 1.58 (90.59%)	20.33M
YIBOPlanet Image International Ltd	$ 5.87 (90.58%)	13.74M
ZKINZK International Group Co Ltd	$ 0.90 (32.35%)	11.13M
NVDANVIDIA Corporation	$ 122.34 (3.31%)	9.81M